{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T06:39:37Z","timestamp":1777444777138,"version":"3.51.4"},"reference-count":43,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,1]]},"DOI":"10.1097\/fjc.0b013e31802cb88e","type":"journal-article","created":{"date-parts":[[2007,1,29]],"date-time":"2007-01-29T09:00:58Z","timestamp":1170061258000},"page":"56-63","source":"Crossref","is-referenced-by-count":37,"title":["2-Methoxyestradiol and 2-Ethoxyestradiol Retard the Progression of Renal Disease in Aged, Obese, Diabetic ZSF1 Rats"],"prefix":"10.1097","volume":"49","author":[{"given":"Xinchen","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Youhong","family":"Jia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edwin K","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stevan P","family":"Tofovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-9-20210208","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1056\/NEJM197403282901301","article-title":"Accelerated atherosclerosis in prolonged maintenance hemodialysis.","volume":"290","author":"Linder","year":"1974","journal-title":"N Engl J Med"},{"key":"R2-9-20210208","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1093\/ndt\/13.6.1430","article-title":"Differences between men and women with chronic renal disease.","volume":"13","author":"Coggins","year":"1988","journal-title":"Nephrol Dial Transplant"},{"key":"R3-9-20210208","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1053\/ajkd.2000.19928","article-title":"Cardiovascular disease in chronic renal insufficiency.","volume":"36","author":"Levin","year":"2002","journal-title":"Am J Kid Dis"},{"key":"R4-9-20210208","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1001\/archinte.163.12.1417","article-title":"Progression of chronic renal failure.","volume":"163","author":"Yu","year":"2003","journal-title":"Arch Intern Med"},{"key":"R5-9-20210208","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/0272-6386(95)90119-1","article-title":"The impact of gender on the progression of chronic renal disease.","volume":"25","author":"Silbiger","year":"1995","journal-title":"Am J Kid Disease"},{"key":"R6-9-20210208","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1681\/ASN.V112319","article-title":"Effects of gender on the progression of nondiabetic renal disease: meta-analysis.","volume":"11","author":"Neugarten","year":"2000","journal-title":"J Am Soc Nephrol"},{"key":"R7-9-20210208","doi-asserted-by":"crossref","first-page":"S117","DOI":"10.1016\/S0272-6386(00)70239-3","article-title":"Cardiovascular disease and chronic renal disease: A new paradigm.","volume":"35","author":"Samak","year":"2000","journal-title":"Am J Kid Dis"},{"key":"R8-9-20210208","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1056\/NEJM199906103402306","article-title":"The protective effects of estrogen on cardiovascular system.","volume":"340","author":"Mendelson","year":"1999","journal-title":"N Engl J Med"},{"key":"R9-9-20210208","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/S0735-1097(01)01450-4","article-title":"Renal Insufficiency and cardiovascular events in postmenopausal women with coronary heart disease.","volume":"38","author":"Shlipak","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"R11-9-20210208","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1001\/archinte.164.9.934","article-title":"Women and heart disease: The role of diabetes and hyperglycemia.","volume":"164","author":"Barrett-Connor","year":"2004","journal-title":"Arch Intern Med"},{"key":"R12-9-20210208","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1001\/jama.280.7.605","article-title":"Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen\/progestin Replacement Study (HERS) Research Group.","volume":"280","author":"Hulley","year":"1998","journal-title":"JAMA"},{"key":"R13-9-20210208","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.288.3.321","article-title":"Writing Group for the Womens Health Initiative Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Womens Health Initiative randomized controlled trial.","volume":"288","author":"Rossouw","year":"2002","journal-title":"JAMA"},{"key":"R14-9-20210208","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1124\/jpet.103.058057","article-title":"Cardiovascular pharmacology of estradiol metabolites.","volume":"308","author":"Dubey","year":"2004","journal-title":"J Pharmacol Exp Ther"},{"key":"R15-9-20210208","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/carcin\/19.1.1","article-title":"Functional role of estrogen metabolism in target cell: review and perspectives.","volume":"19","author":"Zhu","year":"1988","journal-title":"Carcinogenesis"},{"key":"R16-9-20210208","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1097\/01.ASN.0000031804.77546.F5","article-title":"2-Hydroxyestradiol attenuates renal disease in chronic puromycin aminonucleoside nephropathy.","volume":"13","author":"Tofovic","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"R17-9-20210208","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/01.fjc.0000162765.89437.ae","article-title":"Estradiol metabolites attenuate renal and cardiovascular injury induced by chronic nitric oxide synthase inhibition.","volume":"46","author":"Tofovic","year":"2005","journal-title":"J Cardiovasc Pharmacol"},{"key":"R18-9-20210208","first-page":"416","article-title":"Estradiol metabolites attenuate renal and cardiovascular injury induced by chronic angiotensin II administration.","volume":"42","author":"Tofovic","year":"2003","journal-title":"Hypertension"},{"key":"R19-9-20210208","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/S0022-3565(24)29219-3","article-title":"2-Hydroxyestradiol attenuates the development of obesity, metabolic syndrome, and vascular and renal dysfunction in obese ZSF1 rats.","volume":"299","author":"Tofovic","year":"2001","journal-title":"J Pharm Exp Ther"},{"key":"R20-9-20210208","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1021\/jm00012a003","article-title":"Synthesis, antitubulin and antimitotic activity, and cytotoxicity of analogs of 2-methoxyestradiol, an endogenous mammalian metabolite of estradiol that inhibits tubulin polymerization by binding to the colchicine binding site.","volume":"38","author":"Cushman","year":"1995","journal-title":"J Med Chem"},{"key":"R21-9-20210208","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1124\/mol.57.3.568","article-title":"A steroid derivative with paclitaxel-like effects on tubulin polymerization.","volume":"57","author":"Verdier-Pinard","year":"2001","journal-title":"Mol Pharmacol"},{"key":"R22-9-20210208","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1081\/JDI-100100882","article-title":"Renal function and structure in diabetic, hypertensive, obese ZDF x SHHF-hybrid rats.","volume":"22","author":"Tofovic","year":"2000","journal-title":"Renal Failure"},{"key":"R23-9-20210208","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1046\/j.1523-1755.2002.00278.x","article-title":"Long-term caffeine consumption exacerbates renal failure in obese, diabetic, ZSF1 [fa-fa(cp)] rats.","volume":"61","author":"Tofovic","year":"2002","journal-title":"Kidney Int"},{"key":"R24-9-20210208","first-page":"29","article-title":"Animal models of the metabolic syndrome.","volume":"86","author":"Tofovic","year":"2003","journal-title":"Methods Mol Med"},{"key":"R25-9-20210208","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1080\/09553000110069335","article-title":"Proliferating cell nuclear antigen (PCNA): ringmaster of the genome.","volume":"77","author":"Paunesku","year":"2001","journal-title":"Int J Radiat Biol"},{"key":"R26-9-20210208","first-page":"E1089","article-title":"Differential activation of NF- B and Ap-1 in increased fibronectin synthesis in target organs of diabetic complications.","volume":"284","author":"Chen","year":"2003","journal-title":"Am J Physiol"},{"key":"R27-9-20210208","first-page":"467","article-title":"Treatment of insulin resistance with peroxisome proliferator-activated receptor [gamma] agonists J Clin Invest.","volume":"106","author":"Olefsky","year":"2000","journal-title":""},{"key":"R28-9-20210208","first-page":"497","article-title":"Antimitogenic effects of 2-methoxyestradiol, an endogenous metabolite of estradiol, are blocked by PPAR gamma antagonist: Is 2-methoxyestradiol an endogenous PPAR gamma ligand.","volume":"44","author":"Dubey","year":"2004","journal-title":"Hypertension"},{"key":"R29-9-20210208","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1046\/j.1523-1755.2001.059002415.x","article-title":"Transcription factor-B (NF-B) and renal disease.","volume":"59","author":"Guijarro","year":"2001","journal-title":"Kidney Int"},{"key":"R30-9-20210208","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1046\/j.1523-1755.1999.00529.x","article-title":"Inhibition of nuclear factor-kappa B activation reduces cortical tubulointerstitial injury in proteinuric rats.","volume":"56","author":"Rangan","year":"1999","journal-title":"Kidney Int"},{"key":"R31-9-20210208","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1016\/S0002-9440(10)64425-2","article-title":"Nuclear factor-kappa B inhibitors as potential novel anti-inflammatory agents for the treatment of immune glomerulonephritis.","volume":"161","author":"Lopez-Franco","year":"2002","journal-title":"Am J Pathol"},{"key":"R32-9-20210208","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1111\/j.1523-1755.2004.00621.x","article-title":"The role of vascular endothelial growth factor (VEGF) in renal pathophysiology.","volume":"65","author":"Schrijvers","year":"2004","journal-title":"Kidney Int"},{"key":"R33-9-20210208","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.2337\/diabetes.48.11.2229","article-title":"Increased renal expression of vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 in experimental diabetes.","volume":"48","author":"Cooper","year":"1999","journal-title":"Diabetes"},{"key":"R34-9-20210208","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/labinvest.3780392","article-title":"Podocyte injury promotes progressive nephropathy in zucker diabetic rats.","volume":"82","author":"Hoshi","year":"2002","journal-title":"Lab Invest"},{"key":"R35-9-20210208","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.bbrc.2005.06.078","article-title":"PPAR gamma agonists diminish serum VEGF elevation in diet-induced insulin resistant SD rats and ZDF rats.","volume":"334","author":"Yang","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"key":"R36-9-20210208","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1093\/ndt\/gfg242","article-title":"The emerging role of VEGF in diabetic kidney disease.","volume":"18","author":"Khamaisi","year":"2003","journal-title":"Nephrol Dial Transplant"},{"key":"R37-9-20210208","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1681\/ASN.V125993","article-title":"Antibodies against vascular endothelial growth factor improve early renal dysfunction in experimental diabetes.","volume":"12","author":"De Vriese","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"R38-9-20210208","doi-asserted-by":"crossref","first-page":"3090","DOI":"10.2337\/diabetes.51.10.3090","article-title":"Amelioration of long-term renal changes in obese type 2 diabetic mice by a neutralizing vascular endothelial growth factor antibody.","volume":"51","author":"Flyvbjerg","year":"2002","journal-title":"Diabetes"},{"key":"R39-9-20210208","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/86490","article-title":"Vascular endothelial growth factor enhances atherosclerotic plaque progression.","volume":"7","author":"Celletti","year":"2001","journal-title":"Nat Med"},{"key":"R40-9-20210208","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1161\/hc0902.104718","article-title":"Vascular endothelial growth factor is necessary in the development of arteriosclerosis by recruiting\/activating monocytes in a rat model of long-term inhibition of nitric oxide synthesis.","volume":"105","author":"Zhao","year":"2002","journal-title":"Circulation"},{"key":"R41-9-20210208","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1159\/000057401","article-title":"A potential role for angiotensin II-induced vascular endothelial growth factor expression in the pathogenesis of diabetic nephropathy.","volume":"24","author":"Williams","year":"1988","journal-title":"Miner Electrolyte Metab"},{"key":"R42-9-20210208","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1097\/01.LAB.0000017372.76297.EB","article-title":"Angiotensin II angiogenic effect in vivo involves vascular endothelial growth factor- and inflammation-related pathways.","volume":"82","author":"Tamarat","year":"2002","journal-title":"Lab Invest"},{"key":"R43-9-20210208","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1023\/A:1026543018478","article-title":"2-Methoxyestradiol: an endogenous antiangiogenic and antiproliferative drug candidate.","volume":"19","author":"Pribluda","year":"2000","journal-title":"Cancer Metastasis Rev"},{"key":"R44-9-20210208","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.drup.2003.10.001","article-title":"Mechanism of action of 2-methoxyestradiol: new developments.","volume":"6","author":"Mooberry","year":"2003","journal-title":"Drug Resist Updat"}],"container-title":["Journal of Cardiovascular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00004691-200606000-00001","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,13]],"date-time":"2025-01-13T06:53:16Z","timestamp":1736751196000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005344-200701000-00009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,1]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.1097\/fjc.0b013e31802cb88e","relation":{},"ISSN":["0160-2446"],"issn-type":[{"value":"0160-2446","type":"print"}],"subject":[],"published":{"date-parts":[[2007,1]]}}}